Live Breaking News & Updates on Chief Business Officer Jacob Van Naarden

Stay updated with breaking news from Chief business officer jacob van naarden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Founder of Stamford-based Loxo Oncology launches another biotech firm


Founder of Stamford-based Loxo Oncology launches another biotech firm
FacebookTwitterEmail
Dr. Joshua Bilenker, founder and then-CEO of Loxo Oncology, makes a point during an interview at the company’s main offices on Tresser Boulevard in downtown Stamford, Conn., on July 18, 2017.Michael Cummo / Hearst Connecticut Media
STAMFORD Dr. Josh Bilenker, the founder and former CEO of Stamford-based Loxo Oncology, one of the most influential cancer-focused startups of recent years, has launched another locally based oncology firm.
Treeline Biosciences aims to “prioritize molecular targets in oncology that are validated but difficult to drug” and “if successful, we believe that our approaches could apply to other therapeutic areas as well,” Bilenker and Treeline’s other founder, Dr. Jeff Engelman, wrote in a message posted on the firm’s website. ....

United States , San Diego , Rihanna Plaza , Jacob Van Naarden , Van Naarden , Josh Bilenker , Christian Abraham Hearst , Enrique Plaza , Michael Cummo Hearst , Jake Van Naarden , Joshua Bilenker , Exchange Commission , Ajax Health Zeus , Novartis Institutes For Biomedical Research , Access Industries , T Rowe Price Associates , Eli Lilly Co , Novartis Institutes , Casdin Capital , Price Associates , Chief Business Officer Jacob Van Naarden , Tresser Boulevard , Eli Lilly , Loxo Oncology , Michael Cummo , Hearst Connecticut ,